Global Breast Implants Market is projected to register a substantial CAGR of 8.1% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below.
Access Full Report at https://www.databridgemarketresearch.com/reports/global-breast-implants-market
Global breast implants market is an upcoming market which includes key players and local players. The market is growing to the favourable market scenario. The market has a prominent growth in upcoming years due to increasing prevalence of breast cancer and growing awareness towards restoration options.
ALLERGAN dominated the breast implants market and accounts for the highest market share in 2018 which is followed by Johnson & Johnson Services, Inc., CEREPLAS,. The other key players existing in the market are Sientra Inc., Arion Laboratories, Gc Aesthetics Plc Shanghai Kangning Medical Device Co. Ltd., Polytech Health & Aesthetics Gmbh, Hansbiomed Co. Ltd., Guangzhou Wanhe Plastic Materials Co., Ltd. Establishment Labs S.A. and Groupe Sebbin Sas., among others
ALLERGAN:
ALLERGAN headquartered in Dublin, Ireland was incorporated in 2013. The company help their customers to accelerate development, manufacturing and commercializing branded pharmaceutical, biologic, device, surgical and regenerative medicine products for patients around the world. The company deals US specialized therapeutics, US general medicine, international, other business categories. The market focus products comes under US specialized therapeutics business segment. .
It has its global presence through its subsidiaries ZELTIQ Aesthetics, Inc. (U.S.), Bonti, Inc. (U.S.), Allergan Medical (U.S.), Kythera Biopharmaceuticals, Inc. (U.S.), Oculeve, Inc.(U.S.) among others.
It has its global networks through direct sales representatives and distributors in Asia-Pacific, Europe, North America, South Africa and Middle East & Africa.
- On August 2019, Allergan plc has launched online resource for patients, surgeons and healthcare professionals which are related to the recall of textured breast implants BIOCELL. This feature helps patients to understand the breast implant properly and how it can benefit the patient.
Johnson & Johnson Services, Inc.:
Johnson & Johnson Services, Inc. headquartered in New Jersey, U.S. was founded in 1886. The company focused on research and development, manufacturing and sale of a wide range of products in the health care field. The company mainly manages their operation in pharmaceutical, medical devices, and consumer. The market focus category lies under medical devices...
It has its global networks through subsidiaries in Janssen Global Services, LLC (Belgium), Neutrogena (U.S.), DePuy Synthes (U.S.), Ethicon USA, LLC. (U.S.) and Janssen Global Services,LLC (Belgium) among others.
It has its global networks through direct sales representatives and distributors in Asia-Pacific, Europe, North America and South America.
In September 2018, Mentor launched a novel tissue expander with a smooth surface for all the patients undertaking breast implantation. MENTOR has declared that it has launched new product for breast implants with an even surface in United States. There will more cases which will be diagnosed in future and these products will be used to treat the disease.
CEREPLAS:
Cereplas headquartered in France was founded in 1994. The company focuses on the manufacturing of the post-operative pressure garments in aesthetic and plastic surgery as well as also provides custom-made pressure garments for burn management. The market focus products lie under breast implants. The company deals into breast implants, garments, dressings, lipomatic.
It has its global networks through direct sales representatives and distributors in Asia-Pacific, South America, Europe, North America, Middle East and Africa.
